Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺43.177,42, with a 24-hour trading volume of ₺195,42B. The asset's market cap is ₺38,64T, after moving 1.58% in the last day.
Tokenized Eli Lilly And Co is trading at ₺43.342,53, with a tokenized market cap of ₺230,99M and a 24-hour trading volume of ₺415,24M. The tokenized asset has moved 2.29% in the past 24 hours.